Shelley Andrus, APRN
Psychiatric/Mental Health · Great Falls, MTNPI 1962786806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$209
- Johnson & Johnson$145
- Otsuka America Pharmaceutical, Inc.$143
- Neurocrine Biosciences, Inc.$136
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$120
- Teva Pharmaceuticals USA, Inc.$74
- plus $270 from 5 others
What the payments were for
- Food & beverage$1,097100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $209 |
| Johnson & Johnson | 8 | $145 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| Neurocrine Biosciences, Inc. | 8 | $136 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $120 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| Alkermes, Inc. | 4 | $71 |
| Sunovion Pharmaceuticals Inc. | 5 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Indivior Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $40 |
How this compares
$1,097 in reported general payments places this provider in the 90th percentile of 142 psychiatric/mental health providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $2,049 |
| Methylphenidate Hcl | 36 | $912 |
| Aripiprazole | 45 | $649 |
| Lamotrigine | 90 | $605 |
| Bupropion XlBupropion Hcl | 35 | $558 |
| Trazodone Hcl | 52 | $440 |
| Mirtazapine | 17 | $424 |
| Fluoxetine Hcl | 32 | $419 |
| Quetiapine Fumarate | 25 | $406 |
| Atomoxetine Hcl | 11 | $385 |
| Duloxetine Hcl | 17 | $318 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $279 |
| Gabapentin | 18 | $231 |
| Lithium Carbonate | 30 | $170 |
| Sertraline Hcl | 15 | $148 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Great Falls
- Jill DonaldsonGreat Falls$3K
- William BowdenGreat Falls$2K
- Karlee HamiltonGreat Falls$1K
- David JanschGreat Falls$752
- Sara ReynoldsGreat Falls$262
- Tommie PerusichButte$4K
- Heather BrownKalispell$3K
- Sherry MartinMissoula$3K
- Jennifer DurwardHavre$2K
- Susan FinnBillings$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.